Mehrotra et al. found that vaccination with peptide-pulsed DCs combined with the toll-like receptor (TLR)-3 agonist poly-ICLC is a potential therapeutic method for inhibiting metastasis of PC by generating CD8+ T cells [17]. The gene discussed is CD8A; the disease is pachyonychia congenita.